Navigation Links
Graft-versus-Host Diseases can Be Predicted

Human-to-human organ transplantation saves and enhances the lives of a number of patients suffering from many forms of end-stage organ failure//. Today, transplantation is the leading form of treatment for several debilitating diseases.

Graft-versus-host disease occurs when white blood cells from the donor attack tissues of the recipient. It is a very serious complication after stem cell transplantation from related or unrelated donors and may represent a cause of death in 30 to 50 percent of patients.

Graft-versus-host disease is a complication of allogeneic hematopoietic cell transplantation, which results from recognition of recipient antigens by immune T cells from the donor.

Two papers published this week investigate how graft versus host disease might be predicted after hematopoietic cell transplantation.

In the first paper “Prediction of Graft-Versus-Host Disease by Gene-Expression Profiling of Donors” Claude Perreault and colleagues from the University of Montreal tested whether some donors may react more strongly against recipient cells than others. Using microarrays, they measured the gene-expression profiles of CD4+ and CD8+ T cells from 50 donors and were able to show that donor gene-expression profile in these cells had a strong influence on the occurrence of graft-versus-host disease in the recipient.


Page: 1

Related medicine news :

1. In Chronic Diseases - Poor compliance of Patients with drug treatment
2. ICMR along with other International Research organisation with drug development for Neglected Diseases
3. Chronic Diseases said to Cause Falls in the Elderly
4. Viagra Also Found To Be Effective For Treatment of Lung Diseases
5. The Drug Tetrathiomolybdate Found To Be Useful For Various Diseases
6. New Oral Medication That Could Arrest Autoimmune Diseases In its early Stages
7. New Diseases
8. Incidence Of Sexually Transmitted Diseases Among Gay Men On The Rise
9. Controlled Gene Expressions Can Cure Many Diseases
10. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
11. Digoxin Pill To Fight Against Both Heart Diseases And Cancer
Post Your Comments:

(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of the ... stellar workplace culture with the company’s Cincinnati office being named a finalist among ... was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is donating ... Beat ” campaign. The partnership between the two groups began in 2014 with Vitalalert ... cause. , MAP International was founded in 1954 and is an international Christian-based health ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health ... launches new Wimbledon Athletics Facebook page to educate the public, parents ... cardiac abnormalities. About 2,000 people under the age of 25 die from sudden ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a ... tracking systems. The new app features a more intuitive SleepScore™ that rates sleep quality ... you slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015 On Tuesday, November ... bellwether trial against Wright Medical Technology, Inc. for ... Conserve metal-on-metal hip implant device, awarded $11 million ... two week trial and three days of deliberations, ... device was defectively designed and unreasonably dangerous, and ...
(Date:11/25/2015)... Allergan plc (NYSE: AGN ) today announced that it ... State Attorney General,s Office to end the litigation ... with the Attorney General over the decision of Forest Laboratories, ... the now generic version of memantine immediate release tablets.  Under ... its counterclaims against New York , and ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 Endo International ... Rajiv De Silva , President and CEO, will discuss ... Healthcare Conference in New York on ... . Click on Investor Relations, and then the ... prior to the presentation,s start time to visit the site ...
Breaking Medicine Technology: